Advertisement

Atrial Fibrillation: New Insights into Electrophysiologic Mechanisms

  • E. N. Prystowsky
  • B. J. Padanilam
Conference paper

Abstract

Anyone who considers the mechanism(s) of a tachyarrhythmia in humans must address both potential arrhythmia triggers as well as anatomic substrate. The anatomic substrate includes not only alterations in the myocardial architecture (for example fibrosis), but also ion channel disturbances. Arrhythmia triggers are protean and typically multiple in a given individual. For example, it is common for a patient with atrial fibrillation (AF) to relate onset of their arrhythmia on one occasion during sleep but on another occasion during activity. Further, while a patient may be susceptible to a specific trigger (for example alcohol or caffeine) it is very uncommon for the ingestion of such substances consistently to initiate their tachycardia. The diversity and complexity of arrhythmia triggers for a specific patient make it very difficult to target suppression of the triggers as the therapeutic pharmacologic goal.

Keywords

Atrial Fibrillation Pulmonary Vein Left Atrium Catheter Ablation Accessory Pathway 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Prystowsky EN, Klein GJ (1994) Cardiac arrhythmias: an integrated approach for the clinician. McGraw-Hill, New YorkGoogle Scholar
  2. 2.
    Prystowsky EN, Katz A (2002) Atrial fibrillation. In: Topol EJ (ed) Textbook of cardiovascular medicine, 2nd edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  3. 3.
    Davies MJ, Pomerance A (1972) Pathology of atrial fibrillation in man. Br Heart J 34:520–525PubMedCrossRefGoogle Scholar
  4. 4.
    Prystowsky EN, Klein GJ, Rinkenberger RL, Heger JJ, Naccarelli GV, Zipes DP (1984) Clinical efficacy and electrophysiologic effects of encainide in patients with the Wolff-Parkinson-White syndrome. Circulation 69:278–287PubMedCrossRefGoogle Scholar
  5. 5.
    Kerr CR, Prystowsky EN, Smith WM, Cook L, Gallagher JJ (1982) Electrophysiological effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome. Circulation 65:869–878PubMedCrossRefGoogle Scholar
  6. 6.
    Fuster V, Ryden LE, Asinger RW et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). J Am Coll Cardiol 38:1266i-lxxCrossRefGoogle Scholar
  7. 7.
    Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 285:2370–2375PubMedCrossRefGoogle Scholar
  8. 8.
    Bharati S, Lev M (1992) Histology of the normal and diseased atrium. In: Falk RH, Podrid PJ (eds) Atrial fibrillation: mechanisms and management. Raven Press, New YorkGoogle Scholar
  9. 9.
    Frustaci A, Chimenti C, Bellocci F et al (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96:1180–1184PubMedCrossRefGoogle Scholar
  10. 10.
    Maixent IM, Paganelli F, Scaglione J et al (1998) Antibodies against myosin in sera of patients with idopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 9:612–617PubMedCrossRefGoogle Scholar
  11. 11.
    Prystowsky EN, Margiotti R, Fogel RI et al (1996) Atrial fibrillation with and without heart disease: clinical characteristics and proarrhythmia risk. Circulation 94:555–191Google Scholar
  12. 12.
    Levy S, Maarek M, Coumel P et al, for the College of French Cardiologists (1999) Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. Circulation 99:3028–3035PubMedCrossRefGoogle Scholar
  13. 13.
    Nakao K, Seto S, Ueyama C et al (2002) Extended distribution of prolonged and fractionated right atrial electrograms predicts development of chronic atrial fibrillation in patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 13:996–1002PubMedCrossRefGoogle Scholar
  14. 14.
    Reiter MJ (2000) Contraction-excitation feedback. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology: from cell to bedside. Sauders, Philadelphia, pp 249–255Google Scholar
  15. 15.
    Madrid AH, Bueno MG, Rebollo JMG et al (2002) Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 106:331–336PubMedCrossRefGoogle Scholar
  16. 16.
    Moe GK, Abildskov JA (1959) Atrial fibrilltion as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 58:59–70PubMedCrossRefGoogle Scholar
  17. 17.
    Moe GK, Rheinboldt WC, Abildskov JA (1964) A computer model of atrial fibrillation. Am Heart J 67:200–220PubMedCrossRefGoogle Scholar
  18. 18.
    Allessie MA, Lammers WJEP, Bonke FIM et al (1985) Experimental evaluation of Moe’s multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J (eds) Cardiac arrhythmias. Grune & Stratton, New York, pp 265–276Google Scholar
  19. 19.
    Spach MS, Boineau JP (1997) Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol 20[Pt II]:397–413Google Scholar
  20. 20.
    Spach MS, Dolber PC, Heidlage JF (1988) Influence of the passive anisotropic properties on directional differences in propagation following modification of the sodium conductance in human atrial muscle: a model of reentry based on anisotropic discontinuous propagation. Circ Res 62:811–832PubMedCrossRefGoogle Scholar
  21. 21.
    Ravi M, Allan S, Chen J, Berenfeld O, Jalife J (2000) Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 101:194–208CrossRefGoogle Scholar
  22. 22.
    Scherf D, Romano FJ, Terranova R (1948) Experimental studies on auricular flutter and auricular fibrillation. Am Heart J 36:241PubMedCrossRefGoogle Scholar
  23. 23.
    Scherf D, Schaffer AI, Blumenfeld S (1953) Mechanism of flutter and fibrillation. Arch Intern Med 91:333–352CrossRefGoogle Scholar
  24. 24.
    Jais P, Haïssaguerre M, Shah DC (1997) A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 95:572–576PubMedCrossRefGoogle Scholar
  25. 25.
    Haïssaguerre M, Jais P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666PubMedCrossRefGoogle Scholar
  26. 26.
    Nathan H, Eliakim M (1966) The junction between the left atrium and the pulmonary veins: an anatomic study of human hearts. Circulation 34:412–422PubMedCrossRefGoogle Scholar
  27. 27.
    Cheung DW (1981) Pulmonary vein as an ectopic focus in digitalis-induced arrhythmias. Nature 294:582–584PubMedCrossRefGoogle Scholar
  28. 28.
    Chen SA, Tai CT, Yu WC et al (1999) Right atrial focal atrial fibrillation: electrophysiologic characteristics and radiofrequency catheter ablation. J Cardiovasc Electrophysiol 10:328–335PubMedCrossRefGoogle Scholar
  29. 29.
    Hwang C, Karageuzian HS, Chen PS (1999) Idiopathic paroxysmal atrial fibrillation induced by a focal discharge mechanism in the left superior pulmonary vein: possible roles of the ligament of Marshall. J Cardiovasc Electrophysiol 10:636–648PubMedCrossRefGoogle Scholar
  30. 30.
    Chen YJ, Chen SH, Chen YC et al (2001) Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation. Circulation 104:2849–2854PubMedCrossRefGoogle Scholar
  31. 31.
    Chen SA, Hsieh MH, Tai CT et al (1999) Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100:1879–1886PubMedCrossRefGoogle Scholar
  32. 32.
    Jais P, Hocini M, Macle L et al (2002) Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 106:2479–2485PubMedCrossRefGoogle Scholar
  33. 33.
    Cox JL, Schuessler RB, D’Agostino JH Jr et al (1991) The surgical treatment of atrial fibrillation, III: development of a definitive surgical procedure. J Thorac Cardiovasc Surg 101:569–583PubMedGoogle Scholar
  34. 34.
    Hioki M, Ikeshita M, Iedokoro Y et al (1993) Successful combined operation for mitral stenosis and atrial fibrillation. Ann Thorac Surg 55:776–778PubMedCrossRefGoogle Scholar
  35. 35.
    Melo J, Adragao P, Neves J et al (1999) Surgery for atrial fibrillation using radiofrequency catheter ablation: assessment of results at one year. Eur J Cardiothorac Surg 15:851–854PubMedCrossRefGoogle Scholar
  36. 36.
    Kottkamp H, Hindricks G, Autschbach RR et al (2002) Specific linear left atrial lesions in atrial fibrillation. Intraoperative radiofrequency ablation using minimally invasive surgical techniques. J Am Coll Card 40(3):475–480CrossRefGoogle Scholar
  37. 37.
    Haïssaguerre M, Shah DC, Jais P et al (2000) Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 102:2463–2465PubMedCrossRefGoogle Scholar
  38. 38.
    Pappone C, Rosanio S, Oreto G et al (2000) Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 102:2619–2628PubMedCrossRefGoogle Scholar
  39. 39.
    Marrouche NF, Dresing T, Cole C et al (2002) Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation. Impact of different catheter technologies. J Am Coll Card 40(3):464–474CrossRefGoogle Scholar
  40. 40.
    Gerstenfeld EOP, Dixit S, Callans D et al (2002) Utility of exit block for identifying electrical isolation of the pulmonary veins. J Cardiovasc Electrophysiol 13:972–979CrossRefGoogle Scholar
  41. 41.
    Oral H, Knight BP, Ozaydin M et al (2002) Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights. Circulation 106:1256–1262PubMedCrossRefGoogle Scholar
  42. 42.
    Hocini M, Ho SY, Kawara T et al (2002) Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation. Circulation 105:2442–2448PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • E. N. Prystowsky
    • 1
  • B. J. Padanilam
    • 1
  1. 1.The Care GroupLLCIndianapolisUSA

Personalised recommendations